News | January 18, 2011

Carotid Stenting Helps When Drugs, Thrombectomy Do Not


January 19, 2011 – Stents can open up blocked brain arteries after other stroke treatments have failed, according to research presented this week at the 23rd annual International Symposium on Endovascular Therapy (ISET).

In research conducted at the Baptist Cardiac and Vascular Institute in Miami, stents were placed in the blocked brain arteries of 19 acute stroke patients who had not been helped by clot-busting drugs or clot-removal devices. The stents opened up the arteries in 18 of the 19 patients (95 percent), and this resulted in 12 (63 percent) who had minimal or no deficits. Five patients (26 percent) died from major strokes.

If stents hadn’t been used to restore blood flow after these serious strokes, mortality or severe disability would have occurred in approximately 80 to 90 percent of patients, said Italo Linfante, M.D., director of endovascular neurosurgery at the Institute. Currently, using stents to treat acute stroke is an experimental procedure of last resort, used when all other methods have failed.

“FDA-approved treatments to restore blood flow in acute ischemic stroke work 40 to 60 percent of the time. If the artery remains blocked, the patient will suffer death or severe disability,” Linfante said. “Our findings suggest stents can work when clot-busting drugs and clot-removal devices do not, and are a safe and feasible option.”

Stroke is the third-leading cause of death in the United States. Most strokes (85 percent) are caused by a blocked blood vessel, which stops blood flow and oxygen to the brain and causes the brain tissue to die. Treating a stroke quickly can stop further damage, prevent or lessen disability and avert death. Approved treatments include breaking up the clot with drugs, removing it with a corkscrew-like device and vacuuming it out.

Stents have long been used preventatively to open up clogged heart and neck arteries to thwart stroke and heart attack. Scientists have recently discovered that stents may also be used as a treatment device, meaning doctors place them in blocked arteries to treat heart attacks and strokes.

The International Symposium on Endovascular Therapy (ISET) is attended by physicians, scientists, allied professionals and industry professionals from around the world. The meeting pioneered the use of live cases to promote the multidisciplinary treatment of cardiovascular disease. ISET is presented by Baptist Cardiac and Vascular Institute. ISET 2011 is taking place Jan. 16-20 in Miami Beach, Fla.

For more information: www.ISET.org


Related Content

News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
Subscribe Now